TRH mimetics: Differentiation of antiamnesic potency from antidepressant effect

Bioorganic and Medicinal Chemistry

Volumn 5, Issue 11, 1997, Pages 2029-2040

  Mazurov, Anatoly A ^a,c   Andronati, Sergei A ^a   Korotenko, Tamara I ^a   Sokolenko, Nikolai I ^a   Dyadenko, Alexei I ^a   Shapiro, Yury E ^a   Gorbatyuk, Vitalii Ya ^a   Voronina, Tatyana A ^b  

^a INSTITUTE OF HYDROBIOLOGY   (Ukraine)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; PIRACETAM; PROTIRELIN DERIVATIVE; SCOPOLAMINE;

AMNESIA; ARTICLE; CHEMICAL MODIFICATION; DRUG ACTIVITY; DRUG CONFORMATION; DRUG POTENCY; ELECTROENCEPHALOGRAM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PASSIVE AVOIDANCE;

AMINO ACID SEQUENCE; AMNESIA; ANIMALS; ANOXIA; ANTIDEPRESSIVE AGENTS; AZOCINES; ELECTROENCEPHALOGRAPHY; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PYRAZINES; PYRROLES; RATS; THYROTROPIN-RELEASING HORMONE;

EID: 0030723837     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(97)00141-7     Document Type: Article

References (81)

1. For a recent review of TRH, see O'Leary, R.; O'Connor, B. J. Neurochem. 1995, 65, 953.
2. Bier, J.; Enzmann, F.; Folkers, K.; Bowers, C. Y.; Serially, A. V. Biochem. Biophys. Res. Commun. 1969, 37, 705.
3. Burgus, R.; Dunn, T. F.; Desiderio, D.; Vale, W.; Guillemin, R. C. R. Acad. Sci. (Paris) 1969, 269, 1870.
4. Metcalf, G.; Dettmar, P. W. Lancet 1981, 1, 586.
5. (a) Breese, G. R.; Cott, J. M.; Cooper, B. R.; Prange, A. J.; Lipton, M. A. Life Sci. 1974, 14, 1053.
6. (b) Breese, G. R.; Cott, J. M.; Cooper, B. R.; Prange, A. J.; Lipton, M. A.; Plotnikoff, N. P. J. Pharmacol. Exp. Ther. 1975, 193, 11.
7. (c) Wei, E.; Sigel, S.; Loh, H.; Way, E. L. Nature (London) 1975, 253, 739.
8. (a) Yarbrough, G. Nature (London) 1976, 263, 523.
9. (b) Yarbrough, G. Life Sci. 1983, 33, 111.
10. (c) Horita, A.; Carino, M. A.; Lai, H. Annu. Rev. Pharmacol. Toxicol. 1986, 26, 311.
11. (d) Okada, M. J. Neurochem. 1991, 56, 1544.
12. (e) Stwertka, S. A.; Vincent, G. P.; Gamzu, E. R.; MacNeil, D. A.; Vederese, A. Pharmacol. Biochem. Behav. 1991, 41, 145.
13. Griffiths, E. C. Clin. Sci. 1987, 73, 449.
14. Thyrotropin-Releasing Hormone; Griffiths, E. C.; Bennett, J. R., Eds.; Raven: New York, 1983.
15. Yarbrough, G.; Pomara, M. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 1985, 9, 285.
16. Albert, M.; Jenike, M.; Nixon, R.; Nobel, K. Biol. Psychiatry 1993, 33, 267.
17. Tsuboyama, G. K.; Gabriel, S. S.; Davis, B. M.; Davidson, M.; Lawlor, B. A.; Ware, K.; Davis, K. L.; Mohs, R. S. Biol. Psychiatry 1993, 32, 195.
18. Lafer, B.; Fava, M.; Hammerness, P.; Rosenbaum, J. F. Biol. Psychiatry 1993, 34, 650.
19. Maeda, K.; Yoshimoto, Y.; Yamadori, A. Biol. Psychiatry 1993, 33, 277.
20. Nemeroff, C. B.; Widerlov, E.; Bissette, G.; Walleus, H.; Karlsson, I.; Ekluno, K.; Kills, C. D.; Loosen, P. T.; Vale, W. Science 1984, 226, 1342.
21. Renming, X.; Ishihara, K.; Sasa, M.; Ujihara, H.; Momiyama, T.; Fujita, Y.; Todo, N.; Serikawa, T.; Yamada, J.; Takaori, S. Eur. J. Pharmacol 1992, 223, 185.
22. Kubek, M. J.; Knoblach, S. M.; Sharif, N. A.; Burt, D. R.; Buterbaugh, G. G.; Fuson, K. S. Ann. Neurol. 1993, 33, 70.
23. Duthie, S. M.; Taylor, P. L.; Andersen, L.; Cook, J.; Eidne, K. A. Mol. Cell. Endocrinol. 1993, 95, R11.
24. Alamo, C.; Vallejo, M.; Cuenca, E. Arch. Pharmacol. Toxicol. 1982, 8, 151.
25. Faakkari, P.; Feuerstein, G. Neuropharmacology 1988, 27, 1007.
26. Sharif, N. A.; To, Z.; Whiting, R. L. Biochem. Biophys. Res. Commun. 1989, 161, 1306.
27. McDermott, A. M.; Dickinson, S. L.; Wilkin, G. P. Neurochem. Int. 1992, 20, 307.
28. Olson, G. L.; Cheung, H.-Ch.; Chiang, E.; Madison, V. S.; Sepinwall, J.; Vincent, G. P.; Winokur, A.; Gary, K. A. J. Med. Chem. 1995, 38, 2866.
29. Miyamoto, M.; Yamazaki, N.; Nagaoka, A.; Nigawa, Y. Ann. N. Y. Acad. Sci. 1989, 508.
30. Vonhof, S.; Feuerstein, G. Z.; Cohen, L. A.; Labroo, V. M. Eur. J. Pharmacol. 1990, 180, 1.
31. Crick, F. H. C. J. Mol. Biol. 1966, 19, 548.
32. Zasloff, M. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 5449.
33. Potts, Jr., J. T. In Peptides Hormones; Parsons, J. A., Ed.; University Park: Baltimore, 1976; p 134.
34. (a) Guillemin, R.; Brazeau, P.; Bohlen, P.; Esch, F.; Ling, N.; Wehrenberg, W. B. Science 1982, 218, 585.
35. (b) Spiess, J.; Rivier, J.; Vale, W. Nature (London) 1983, 303, 532.
36. Schröder, E.; Lübke, K. The Peptides, Vol. II; Academic: New York, 1966; pp 52-53.
37. (a) Mazurov, A. A.; Andronati, S. A.; Kabanov, V. M.; Sokolenko, N. I.; Rokachinskaya, M. G.; Shapiro, Yu. E.; Gorbatyuk, V. Ya. Collect. Czech. Chem. Commun. 1990, 55, 2555.
38. (b) Rokachinskaya, M. G.; Golovenko, N. Ya.; Kabanov, V. M.; Mazurov, A. A.; Andronati, S. A. Physiologically Active Compounds (Kiev) 1991, 23, 46.
39. Shapiro, Yu. E.; Gorbatyuk, V. Ya.; Kabanov, V. M.; Mazurov, A. A.; Andronati, S. A.; Lobasyuk, B. A.; Golovenko, N. Ya.; Rokachinskaya, M. G. Sov. J. Bioorg. Chem. 1990, 16, 1607.
40. Mazurov, A. A.; Andronati, S. A.; Lobasyuk, B. A.; Kabanov, V. M.; Korotenko, T. I. Pharm. Chem. J. 1988, 155.
41. Kabanov, V. M.; Mazurov, A. A.; Andronati, S. A. Sov. J. Bioorg. Chem. 1992, 18, 1013, and references therein.
42. Endogenous pyroglutamyl-glutaminyl-prolinamide have been isolated from human seminal fluid: Khan, Z.; Aitken, A.; del Rio Garcia, J.; Smyth, D. G. J. Biol. Chem. 1992, 267, 7464.
43. Deslauriers, R.; Garrigou-Lagrange, Ch.; Bellocq, A.-M.; Smith, I. C. P. FEBS Lett. 1973, 31, 59.
44. (a) Montagut, M.; Lemanceau, B.; Bellocq, A.-M. Biopolymers 1974, 13, 2615.
45. (b) Donzel, B.; Rivier, J.; Goodman, M. Biopolymers 1974, 13, 2631.
46. Gorbatyuk, V. Ya.; Shapiro, Yu. E.; Mazurov, A. A.; Zhuravlyov, V. G.; Andronati, S. A.; Korotenko, T. I.; Romanovsky, P. Ya. Sov. J. Bioorg. Chem. 1992, 18, 235.
47. Burket, U.; Allinger, N. L. Molecular Mechanics, American Chemical Society: Washington, D.C., 1982.
48. Peterson, R. E.; Guillemin, R. G. Amer. J. Med. 1974, 57, 591.
49. Amblard, M.; Rodriguez, M.; Martinez, J. Tetrahedron 1988, 44, 5101.
50. Mazurov, A. A.; Andronati, S. A.; Korotenko, T. I.; Gorbatyuk, V. Y.; Shapiro, Y. E. Int. J. Peptide Protein Res. 1993, 42, 14.
51. Mazurov, A.A.; Antonenko, S. V.; Andronati, S. A. Chemistry of Natural Compounds (USSR) 1986, 208.
52. (a) Andronati, S. A.; Mazurov, A. A. Sov. J. Bioorg. Chem. 1984, 10, 1445.
53. (b) Andronati, S. A.; Mazurov, A.A.; Korotenko, T. I. Chemistry of Peptides and Proteins 1986, 3, 37.
54. Kastin, A. J.; Ehrensing, R. H.; Schalch, D. S.; Anderson, M. S. Lancet 1972, 2, 740.
55. Prange, A. J., Jr.; Wilson, I. C.; Lala, P. P.: Alltop, L. B.; Breese, G. R. Lancet 1972, 2, 999.
56. Coppen, A.; Montgomery, S.; Peet, M.; Bailey, J. Lancet 1974, 2, 433.
57. Ehrensing, R. H.; Kastin, A. J.; Schalch, D. S.; Friesen, H. G.; Vagas, J. R.; Schally, A. V. Am. J. Psychiatry 1974, 131, 714.
58. Montjoy, C. O.; Price, J. S.; Weller, M.; Hunter, P.; Hall, R.; Dewar, J. D. Lancet 1974, 1, 958.
59. Ogawa, N.; Yamawaki, Y.; Kuroda, H.; Ofuji, T.; Itoga, E.; Kito, S. Brain Res. 1981, 205, 169.
60. Ogawa, N.; Yamawaki, Y.; Kuroda, H.; Nukina, I,; Ota, Z.; Fujino, M.; Yanaihara, N. Peptides 1982, 3, 669.
61. Ogawa, N.; Mizuno, S.; Mori, A.; Nukina, I.; Ota, Z.; Yamamoto, M. Peptides 1982, 3, 743.
62. Porsolt, R. D.; Anton, G.; Blavet, N.; Jalfre, M. Eur. J. Pharmacol. 1978, 47, 379.
63. Schindler, U. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 1989, 13 (Suppl.), 99.
64. Banfi, S.; Dorigotti, L. Clin. Neuropharmacol. 1986, 9 (Suppl. 3), S19.
65. Banfi, S.; Cornelli, U.; Fonio, W.; Dorigotti, L. J. Pharmacol. Methods 1982, 8, 255.
66. Pozzi, O.; Allievi, E.; Biagetti, R.; Banfi, S.; Dorigotti, L. Pharmacol. Res. Commun. 1988, 20 (Suppl. 2), 315.
67. Schindler, U.; Rush, D. K.; Fielding, S. Drug Dev. Res. 1984, 4, 567.
68. Verloes, R.; Scotto, A. M.; Gobert, J.; Wlfert, E. Psychopharmacology 1988, 95, 230.
69. Pinza, M.; Farina, C.; Cerri, A.; Pfeiffer, U.; Riccaboni, M. T.; Banfi, S.; Biagetti, R.; Pozzi, O.; Magnani, M.; Dorigotti, L. J Med. Chem. 1993, 36, 4214.
70. Fink, M. Quantitative EEG Analysis and Psychopharmacology; Elsevier: Amsterdam, 1977.
71. Cosentino, U.; Moro, G.; Pitea, D.; Todeschini, R.; Brossa, S.; Gualandi, F.; Scolastico, C.; Giannesi, F. Quant. Struct.-Act. Relat. 1990, 9, 195.
72. Altomare, C.; Cellamare, S.; Carotti, A.; Casini, G.; Ferappi, M.; Gavuzzo, E.; Mazza, F.; Carrupt, P.-A.; Gaillard, P.; Testa, B. J. Med. Chem. 1995, 38, 170.
73. Martinez, J. L., Jr.; Jensen, R. A.; McCaugh, J. L. Prog. Neurobiol. 1981, 16, 155.
74. Butler, D. E.; Nordin, I. C.; L'Italien, Y. L. J. Med. Chem. 1984, 27, 684.
75. Korablyov, M. V.; Lukienko, P. I. Antihypoxic Compounds; Minsk, 1976.
76. Dunham, N. W.; Miya, T. S. J. Amer. Pharm. Assoc. 1957, 46, 208.
77. Boissier, J.-R.; Dumont, C.; Ratouis, R.; Pagny, J. Arch. Int. Pharmacodyn. 1961, 133, 29.
78. Boissier, J.-R.; Simon, P. Thérapie 1962, 17, 1225.
79. EEG in Drug Research; Herrmann, W. M., Ed.; Stuttgart: New York, 1982.
80. Glatt, A.; Duerst, T.; Mueller, B., Demieville, H. Neuropsychobiology 1983, 9, 163.
81. Sharp, F. H.; Smith, G. W. Psychophysiology 1975, 12, 471.